Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 65/100

Failure Rate

21.4%

3 terminated/withdrawn out of 14 trials

Success Rate

57.1%

-29.4% vs industry average

Late-Stage Pipeline

36%

5 trials in Phase 3/4

Results Transparency

25%

1 of 4 completed trials have results

Key Signals

5 recruiting1 with results

Enrollment Performance

Analytics

N/A

3(37.5%)

Phase 4

3(37.5%)

Phase 3

2(25.0%)

8Total

N/A(3)

Phase 4(3)

Phase 3(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (14)

Showing 14 of 14 trials

NCT02921555Phase 4Terminated

Endovenous Corticosteroid Pulses in Moderate Ulcerative Colitis

Role: lead

NCT06844318Recruiting

Impact of IBD Activity on Frailty in Patients Over 60 Years

Role: lead

NCT05698745Recruiting

Immunological Characteristics of Preclinical IBD

Role: lead

NCT07248644Phase 4Not Yet Recruiting

Immunosuppressant Discontinuation in Elderly Patients With Ulcerative Colitis And Long-term Remission

Role: lead

NCT06031038Not ApplicableCompleted

Impact of Telemonitoring in the Management of Complex IBD in Spain: M-TECCU

Role: lead

NCT05271773Completed

Impact of Therapeutic Intervention on Quality of Life in Patients With Ulcerative Colitis

Role: lead

NCT04330846Not ApplicableRecruiting

Prospective Multicenter Randomized Comparative Study of the Treatment of de Novo Stenosis in Chron's Disease.

Role: lead

NCT06469424Recruiting

An Active Surveillance, Post-Authorization Study to Characterize the Safety of Tofacitinib in Patients With Moderately to Severely Active Ulcerative Colitis in the Real-World Setting Using Data From the United Registries for Clinical Assessment and Research (UR-CARE) in the European Union (EU)

Role: lead

NCT02904590Completed

A Prospective Study on the Incidence and Risk Factors Related to Infection in Patients With Inflammatory Bowel Disease

Role: lead

NCT03894228Recruiting

Safety of IBD Drugs During Pregnancy and Breastfeeding: Mothers and Babies' Outcomes (DUMBO Registry)

Role: lead

NCT02395354Not ApplicableUnknown

Comparative Prospective Multicenter Randomized Study of Endoscopic Treatment of Stenosis in Crohn´s Disease

Role: lead

NCT01562951Phase 3Terminated

Assessment of Mucosal Activity to Improve the Prognosis of Patients With Crohn's Disease Treated With Immunosuppressants

Role: lead

NCT00702611Phase 4Terminated

Efficacy Study of Granulocytapheresis Plus Steroids vs Steroids Alone in Active Steroid Dependant Ulcerative Colitis

Role: lead

NCT01564823Phase 3Completed

Adalimumab on Preventing Post-chirurgic Recurrence on Crohn´s Disease

Role: lead

All 14 trials loaded